TY - JOUR
T1 - Corrigendum to “Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer” [Eur Urol 2023;83:313–17] (European Urology (2023) 83(4) (313–317), (S0302283822025386), (10.1016/j.eururo.2022.07.023))
AU - Gil-Jimenez, Alberto
AU - van Dorp, Jeroen
AU - Contreras-Sanz, Alberto
AU - van der Vos, Kristan
AU - Vis, Daniel J.
AU - Braaf, Linde
AU - Broeks, Annegien
AU - Alcaraz, Antonio
AU - Wessels, Lodewyk F.A.
AU - More Authors, null
N1 - Green Open Access added to TU Delft Institutional Repository ‘You share, we take care!’ – Taverne project https://www.openaccess.nl/en/you-share-we-take-care
Otherwise as indicated in the copyright section: the publisher is the copyright holder of this work and the author uses the Dutch legislation to make this work public.
PY - 2023
Y1 - 2023
N2 - The authors regret that the following statement regarding author contributions was missed: Kristan van der Vos is currently a Scientific Editor for Cell Reports Medicine, which is published by Elsevier. Dr van der Vos was not involved in the peer-review process or editorial discussions about this manuscript. The authors would like to apologise for any inconvenience caused.
AB - The authors regret that the following statement regarding author contributions was missed: Kristan van der Vos is currently a Scientific Editor for Cell Reports Medicine, which is published by Elsevier. Dr van der Vos was not involved in the peer-review process or editorial discussions about this manuscript. The authors would like to apologise for any inconvenience caused.
UR - http://www.scopus.com/inward/record.url?scp=85149814572&partnerID=8YFLogxK
U2 - 10.1016/j.eururo.2023.03.002
DO - 10.1016/j.eururo.2023.03.002
M3 - Comment/Letter to the editor
AN - SCOPUS:85149814572
SN - 0302-2838
VL - 83
SP - e165
JO - European Urology
JF - European Urology
IS - 6
ER -